Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anthony C. Segreti"'
Autor:
Noel R. Mohberg, Robert L. Davis, Karl E. Peace, Anthony C. Segreti, Hoi M. Leung, Gary G. Koch
Publikováno v:
Journal of Biopharmaceutical Statistics. 11:347-372
The practice of statistics in the pharmaceutical industry has changed markedly over the last 25 years. This paper examines the evolution of clinical trial statistics in relationship to advances in statistical methodology and computational power as we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ce65408421783f14f14e838d20a483f
https://doi.org/10.1081/bip-120008853
https://doi.org/10.1081/bip-120008853
Autor:
Charles E. Geyer, M. Walker, S. Stein, Xiaolei Zhou, Mayur M. Amonkar, Anthony C. Segreti, David Cella, David Cameron
Publikováno v:
Breast cancer research and treatment. 117(3)
The randomized phase III trial EGF100151 demonstrated that the combination of lapatinib plus capecitabine (L + C) significantly improved time to progression (TTP) compared with capecitabine alone (C) in heavily pretreated patients with HER2+ (ErbB2+)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf3f411c24ad706ea624586ad4ca6d8
https://pubmed.ncbi.nlm.nih.gov/19153829
https://pubmed.ncbi.nlm.nih.gov/19153829
Autor:
Anthony C. Segreti, David Cella, David Cameron, Charles E. Geyer, Xiaolei Zhou, M. Walker, Mayur M. Amonkar, S. Stein
Publikováno v:
European Journal of Cancer Supplements. 6:216-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7001e6d06871fcfa5d1ed9116f6b448b
https://doi.org/10.1016/s1359-6349(08)70881-4
https://doi.org/10.1016/s1359-6349(08)70881-4
Autor:
Anthony C. Segreti, David Cella, Charles E. Geyer, David Cameron, Xiaolei Zhou, Mayur M. Amonkar, S. Stein, M. Walker
Publikováno v:
Journal of Clinical Oncology. 26:9532-9532
9532 Background: In a phase III randomized open-label multicenter trial, L+C improved time to progression and progression free survival vs C alone in women with ErbB2+ MBC who had received prior th...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::445ff6c8f768eebda556dc3d187ac2a3
https://doi.org/10.1200/jco.2008.26.15_suppl.9532
https://doi.org/10.1200/jco.2008.26.15_suppl.9532
Autor:
Anthony C. Segreti, David Cella, M. Arbushites, Y. Wu, M. Walker, Mayur M. Amonkar, M. Koehler, A. DiLeo
Publikováno v:
European Journal of Cancer Supplements. 6:171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c1616f34b00fac5fd7341a8b84ed2d0
https://doi.org/10.1016/s1359-6349(08)70722-5
https://doi.org/10.1016/s1359-6349(08)70722-5
Autor:
Oscar L. Laskin, Ronald E. Keeney, L. E. Kirk, Henry H. Balfour, John A. Zaia, Richard F. Ambinder, Dorothee M. Aeppli, Anthony C. Segreti, James C. Wade, Joel D. Meyers, Bonnie Bean
Publikováno v:
New England Journal of Medicine. 308:1448-1453
We conducted a placebo-controlled, double-blind study of acyclovir therapy for acute herpes zoster in immunocompromised patients. Of the 94 patients enrolled in the study, 52 had localized skin lesions at entry, and 42 had disseminated cutaneous zost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9ca8926a7ff683d5e97f818451ee05
https://doi.org/10.1056/nejm198306163082404
https://doi.org/10.1056/nejm198306163082404
Publikováno v:
Journal of the American Academy of Dermatology. 13:590-596
Topical acyclovir favorably influences the healing of localized herpes zoster in immunocompromised patients. This therapy, or placebo, was applied to forty-three patients in a random access, double-blind trial, four times daily for 10 days, beginning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f6df943b8ba432372104f6570c1f36
https://doi.org/10.1016/s0190-9622(85)70202-2
https://doi.org/10.1016/s0190-9622(85)70202-2
Autor:
Bert Spilker, Anthony C. Segreti
Publikováno v:
Epilepsia. 25:443-449
Summary: A phenomenon known as regression of seizure frequency toward the median was observed in a previous clinical study performed in patients with partial seizures. Regression of seizure frequency is a situation in which patients with a frequency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5121eef7d951a2b7adf334645fac26
https://doi.org/10.1111/j.1528-1157.1984.tb03441.x
https://doi.org/10.1111/j.1528-1157.1984.tb03441.x
Autor:
Anthony C. Segreti, Gary N. Foulks, Jonathan H. Lass, Sharon Chapman, Thomas J. Liesegang, Daniel B. Jones, John E. Sutphin, L. Michael Cobo, Kirk R. Wilhelmus
Publikováno v:
Ophthalmology. 92:1574-1583
A prospective, randomized, double-masked, placebo-controlled clinical trial was conducted to study the effects of oral acyclovir on 55 patients with acute herpes zoster ophthalmicus. Treatment with oral acyclovir resulted in more prompt resolution of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b0a235788351ab129977de40063d9b7
https://doi.org/10.1016/s0161-6420(85)33842-3
https://doi.org/10.1016/s0161-6420(85)33842-3
Autor:
Anthony C. Segreti, Daniel B. Jones, Jonathan H. Lass, Gary N. Foulks, D. H. King, John E. Sutphin, Kirk R. Wilhelmus, T. Liesegang, L. M. Cobo, Sharon Chapman
Publikováno v:
Ophthalmology. 93(6)
Seventy-one nonimmunocompromised patients with herpes zoster ophthalmicus, presenting within seven days of onset of characteristic skin eruption, were enrolled in a prospective, longitudinal, randomized, double-masked, placebo-controlled trial with o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6988c604fa6b5a24ed4f8c9f426806
https://pubmed.ncbi.nlm.nih.gov/3488532
https://pubmed.ncbi.nlm.nih.gov/3488532